Facebook
Toll-free:1-888-852-8623

All categories

  • All categories
  • Flow Cytometry Antibodies
  • ELISA Kits
  • MACS Cell Isolation
  • Antibodies and Reagents
  • Apoptosis and Cell Health Detection
  • Metabolism Assays
  • Immunoassays
  • Cell Identification Kits
  • Proteins and Peptides
  • Cell Culture
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑

Recombinant Phospho-IκB-α (Ser32) Monoclonal Antibody (AN301182L)

Recombinant Phospho-IκB-α (Ser32) Monoclonal Antibody - 1
  • Recombinant Phospho-IκB-α (Ser32) Monoclonal Antibody - 1
  • Recombinant Phospho-IκB-α (Ser32) Monoclonal Antibody - 2
All Size Price Qty
100μL $ 320.00
- +
50μL $ 211.00
- +
Add to cart

For research use only.

Verified Samples Verified Samples in WB: K562
Dilution WB 1:2000-1:10000,  
Isotype IgG,κ
Host Rabbit
Reactivity Human,  Mouse,  Rat
Applications WB
Clonality Monoclonal;Recombinant
Immunogen A synthetic peptide corresponding to residues around (Ser32) of Human Phospho-IκB-α
Abbre IκB-α
Synonyms EDAID,  MAD,  IKBA,  MAD-3,  NFKBI,  IKB alpha,  NFKBIA,  EDAID2,  I kappa B alpha,  IkappaBalpha,  I-kappa-B-alpha,  IKBalpha,  IkB-alpha,  MAD 3,  NF kappa B inhibitor alpha,  MAD3,  alpha,  Major histocompatibility complex enhancer-binding protein MAD3,  NF-kappa-B inhibitor alpha,  Nuclear factor of kappa light chain gene enhancer in B cells,  Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha,  nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,  pIκBα,  IκB α
Swissprot
Calculated MW 36 kDa
Observed MW 40 kDa
The actual band is not consistent with the expectation.

Western blotting is a method for detecting a certain protein in a complex sample based on the specific binding of antigen and antibody. Different proteins can be divided into bands based on different mobility rates. The mobility is affected by many factors, which may cause the observed band size to be inconsistent with the expected size. The common factors include:

1. Post-translational modifications: For example, modifications such as glycosylation, phosphorylation, methylation, and acetylation will increase the molecular weight of the protein.

2. Splicing variants: Different expression patterns of various mRNA splicing bodies may produce proteins of different sizes.

3. Post-translational cleavage: Many proteins are first synthesized into precursor proteins and then cleaved to form active forms, such as COL1A1.

4. Relative charge: the composition of amino acids (the proportion of charged amino acids and uncharged amino acids).

5. Formation of multimers: For example, in protein dimer, strong interactions between proteins can cause the bands to be larger. However, the use of reducing conditions can usually avoid the formation of multimers.

If a protein in a sample has different modified forms at the same time, multiple bands may be detected on the membrane.

Cellular Localization Cytoplasm, Nucleus, Shuttles between the nucleus and the cytoplasm by a nuclear localization signal (NLS) and a CRM1-dependent nuclear export.
Concentration 0.2 mg/mL
Buffer PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification Method Protein A
Research Areas Signal Transduction,  Epigenetics and Nuclear Signaling,  Cancer,  Immunology
Clone No. 9D8
Conjugation Unconjugated
Storage Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Shipping Ice bag
background This gene encodes a member of the NF-kappa-B inhibitor family, which contain multiple ankrin repeat domains. The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses. The encoded protein moves between the cytoplasm and the nucleus via a nuclear localization signal and CRM1-mediated nuclear export. Mutations in this gene have been found in ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant disease.
Other Clones

{{antibodyDetailsPage.numTotal}} Results

Other Formats

{{formatDetailsPage.numTotal}} Results

Unconjugated

  • IF:{{item.impact}}

    Journal:{{item.journal}} ({{item.year}})

    DOI:{{item.doi}}

    Reactivity:{{item.species}}

    Sample Type:{{item.organization}}

  • Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}

Product Information